Skip to Main Content

Paper Details

The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease.
0
2023
AMD, Alzheimer's disease, CETP, HDL, HDL cholesterol, LDL, LDL cholesterol, age-related macular degeneration, anacetrapib, apolipoprotein, apolipoprotein B, cardiovascular disease, cholesterol, cholesteryl ester, cholesteryl ester transfer protein, cholesteryl esters, diabetes, diabetic, high, high-density lipoprotein, low-density lipoprotein, obicetrapib, patients, sepsis, triglyceride, triglycerides, type 2 diabetes mellitus
Author NameAffiliation
John J P KasteleinAcademic Medical Center, University of Amsterdam
  • 1 - 1

Datasets

Release 1.2